Abootalebi Alireza, Khazaei Sepideh, Minakari Mohammad, Nasr-Isfahani Mohammad, Esmailian Mehrdad, Heydari Farhad
Department of Emergency Medicine, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Student Research Committee, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Adv J Emerg Med. 2017 Oct 12;1(1):e7. doi: 10.22114/AJEM.v1i1.17. eCollection 2017 Fall.
Large-volume paracentesis is one of the usual treatments for cirrhotic patients with tense ascites, which may cause different complications including decreased cardiac preload, suppressed renin angiotensin system, inactivation of sympathetic nervous system, electrolyte imbalances, etc.
The aim of this study was to compare the effects of administrating hydroxyethyl starch (HES) and albumin in cirrhotic patients with tense ascites in order to reduce the paracentesis complications.
In the present randomized clinical trial, 108 cirrhotic patients with tense ascites were enrolled. The patients were randomly divided into 3 groups. In group A, albumin 20% with 5 g/L dose of paracentesis fluid, in group B, HES 6% dissolved in saline were administered, and in group C, a combination of albumin 20% and HES 6% with half the dosage administrated to two other groups were prescribed. Then biochemical panel, and liver function tests and renal and electrolyte complications were compared between the groups.
The results obtained after intervention did not show significant differences between the groups regarding weight (p=0.102), heart rate and platelet count (both p=0.094), hematocrit (p=0.09), creatinine (p=0.421), serum sodium (p=0.743) and potassium (p=0.147), total bilirubin (p=0.375) and urine volume (p=0.421). Additionally, we concluded that mean arterial pressure of patients who had received albumin was higher than the other 2 groups (p < 0.001).
The results of the present study showed the similar effects of HES and albumin in cirrhotic patients with tense ascites undergoing large-volume paracentesis.
大量腹腔穿刺放液术是肝硬化腹水患者常用的治疗方法之一,该方法可能会引发不同的并发症,包括心脏前负荷降低、肾素 - 血管紧张素系统受抑制、交感神经系统失活、电解质失衡等。
本研究旨在比较给予羟乙基淀粉(HES)和白蛋白对肝硬化腹水患者的影响,以减少腹腔穿刺放液术的并发症。
在本次随机临床试验中,纳入了108例肝硬化腹水患者。患者被随机分为3组。A组给予20%白蛋白,剂量为每升腹腔穿刺放液量5克;B组给予溶解于生理盐水中的6% HES;C组给予20%白蛋白和6% HES的组合,剂量为其他两组的一半。然后比较各组之间的生化指标、肝功能测试以及肾脏和电解质并发症情况。
干预后结果显示,各组在体重(p = 0.102)、心率和血小板计数(两者p = 0.094)、血细胞比容(p = 0.09)、肌酐(p = 0.421)、血清钠(p = 0.743)和钾(p = 0.147)、总胆红素(p = 0.375)和尿量(p = 0.421)方面无显著差异。此外,我们得出结论,接受白蛋白治疗的患者平均动脉压高于其他两组(p < 0.001)。
本研究结果表明,HES和白蛋白对接受大量腹腔穿刺放液术的肝硬化腹水患者具有相似的效果。